Despite p53‐deficient cancer cells seem to be preferentially sensitized by Wee1 inhibition,19, 20, 21 the correlation between AZD1775 sensitivity and TP53 mutational status is still highly controversial.23, 24, 25. This evidence concerns the gene TP53 and cancer.